Working Life: Les Hughes AstraZeneca's global vice president, cancer and infection research on working his way up from a bench scientist(more)
The Pharmafocus Interview: Elmar Schnee Merck's head of pharmaceuticals on the advantages of a diverse business model and the maddening 'disaster' that is Germany's cost effectiveness body IQWIG(more)
Connecting with customers Thursday , September 15, 2005
How do you ensure your product stands out from the crowd? Dr Paul Stuart-Kregor looks at the art of creating successful communications and advertising programmes. ...(more)
Dealing with the generic threat Wednesday, September 14, 2005
Helen Brown says the generic threat has spurred branded pharma to launch more creative and quicker counter strategies like 'evergreening' and line extensions....(more)
PCTs, points and their progress Wednesday, September 14, 2005
Andrew Platten looks at how the GMS Quality and Outcomes Framework has been developing and the implications and opportunities for the pharma industry....(more)
Handing over the reins of power Wednesday, September 14, 2005
Despite companies like Pfizer and GSK taking the issue of succession planning very seriously, a surprisingly large number of companies don't have formal plans in place....(more)
Advertising workshop Wednesday, September 07, 2005
Starting with how to launch a new brand on to the market, Pharmafocus presents a short guide to some of the fundamental aspects of pharmaceutical advertising....(more)
The evolving world of advertising Tuesday , September 06, 2005
The traditional healthcare advertising model has been blown away as the drive to find new revenue streams forces agencies into a new pattern of consolidation and networks....(more)
Personalising medicine Friday , September 02, 2005
Helen Brown says economic reality is forcing pharma to focus on 'nichebusters', with orphan drug development and personalised medicine starting to come into its own....(more)
How to get inside your customer's head Thursday , September 01, 2005
The purchase of IMS by a consumer company underlines the potential of pharma market research. John Hosken looks at the most effective way to use it and how it is changing....(more)
